Golden State Wealth Management LLC Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Golden State Wealth Management LLC purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 1,714 shares of the healthcare conglomerate's stock, valued at approximately $867,000.

Several other large investors have also bought and sold shares of the company. Kathleen S. Wright Associates Inc. bought a new position in shares of UnitedHealth Group in the third quarter valued at $27,000. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $30,000. West Financial Advisors LLC purchased a new position in shares of UnitedHealth Group in the third quarter worth approximately $32,000. RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group during the 3rd quarter worth approximately $37,000. Finally, Friedenthal Financial acquired a new stake in shares of UnitedHealth Group in the third quarter worth $51,000. Institutional investors own 87.86% of the company's stock.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the business's stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Price Performance

NYSE UNH traded up $1.05 on Tuesday, reaching $534.42. The company's stock had a trading volume of 1,666,212 shares, compared to its average volume of 4,253,529. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The firm has a market cap of $491.82 billion, a PE ratio of 34.46, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The business has a 50-day moving average price of $527.67 and a 200 day moving average price of $564.22. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business's revenue was up 6.8% on a year-over-year basis. During the same period last year, the business earned $5.83 earnings per share. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Analyst Ratings Changes

Several research firms recently commented on UNH. Piper Sandler decreased their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a report on Thursday, January 2nd. Morgan Stanley reduced their price objective on UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating for the company in a research report on Wednesday, October 16th. Barclays reduced their price target on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a report on Friday, January 17th. Hsbc Global Res raised shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Finally, Truist Financial lowered their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group has a consensus rating of "Buy" and an average price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.